NEW DELHI: Pharma stocks were anyway but on investor radar. Now, with fresh concerns over US prosecutors fresh criminal investigation into global generic pharma companies into suspected price collusion, things have become worrisome to worse for the ... Economic Times, 1 month ago
Can investors still count on pharma as a defensive bet or is it time for a rethink? - Economic Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!